Status:
COMPLETED
The Use of Dexmedetomidine for EEG Sedation in Children With Behavioural Disorders
Lead Sponsor:
Azienda Ospedaliera di Padova
Conditions:
Procedural Sedation
Behavior Disorders
Eligibility:
All Genders
1-18 years
Phase:
PHASE2
Brief Summary
Children's compliance during diagnostic or therapeutic procedures is a challenge, often requiring the use of sedative and/or analgesic drugs. Electroencephalogram (EEG) needs stillness for a medium-l...
Detailed Description
Compliance during diagnostic or therapeutic procedures is a very frequent challenge in children. Procedural sedation and analgesia represents an effective answer to this problem. Electroencephalogram ...
Eligibility Criteria
Inclusion
- children affected by behavior disorders who underwent EEG procedure with sedation
- written informed consent
Exclusion
- ASA \> 2
- hypersensitivity of active substance
- therapy with beta blockers or digoxin, arrhythmia
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03799783
Start Date
March 1 2018
End Date
September 28 2019
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Intensive Care Unit - Department of Woman's and Child's Health - Azienda Ospedaliera di Padova
Padua, PD, Italy